Clinical Trials Directory

Trials / Suspended

SuspendedNCT03117504

Assessment of Prevalence of Stress Urinary Incontinence During Pregnancy

Status
Suspended
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Ain Shams Maternity Hospital · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

Stress urinary incontinence is the most common type of incontinence during pregnancy.our study aims at determining the prevalence in the first and third trimesters and the associated risk factors.

Detailed description

The required sample size has been calculated using IBM© Sample Power© version 3 .The primary outcome measure is the prevalence of stress urinary incontinence (SUI) in the 1st and 3rd trimesters. Accordingly, it is estimated that a sample of 240 patients in either study group would have a power of 80% (beta error, 0.2) to detect a statistically significant difference of 9% between the two groups as regards the incidence of SUI. The incidence of SUI is assumed to equal 10% in the 1st trimester. The prevalence of SUI in the 3rd trimester is assumed to equal 10% under the null hypothesis and to equal 19% under the alternative hypothesis. This calculation used a two-sided z test with a confidence level of 95% (alpha error, 0.05). Data will be collected, tabulated, then analyzed using IBM© SPSS© Statistics version 22. Normally distributed numerical data will be presented as mean and SD, and skewed data as median and inter-quartile range. Qualitative data will be presented as number and percentage.Comparison of normally distributed numerical data will be done using the unpaired Student t test. Skewed data will be compared using the Mann-Whitney U test. Categorical data will be compared using the chi-squared test, or Fisher's exact test when appropriate. A two-sided p-value \<0.05 will be considered statistically significant .

Conditions

Interventions

TypeNameDescription
OTHERquestionnairea questionnaire is given to each woman to determine the urinary incontinence and it's impact on quality of life.

Timeline

Start date
2016-01-05
Primary completion
2017-05-20
Completion
2017-07-20
First posted
2017-04-18
Last updated
2017-04-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03117504. Inclusion in this directory is not an endorsement.